Fentanyl has become one of the most serious threats to youth health in the United States, yet many adolescents still do not fully understand how dangerous the drug can be. A recent national study found that a significant number of teenagers do not view fentanyl use as a high-risk behavior, especially when it comes to trying the drug only once or twice.
The findings highlight an urgent need for stronger education efforts aimed at young people, families, schools, and communities. As fentanyl continues to contribute to overdose deaths among adolescents, improving awareness about its dangers may help prevent future tragedies.
Fentanyl is a powerful synthetic opioid that is involved in a large proportion of adolescent overdose deaths. In many cases, young people may not intentionally seek out fentanyl. Instead, the drug can be mixed into counterfeit pills or other substances without the user knowing. This creates a dangerous situation where a person may believe they are taking another drug but unknowingly consume a potentially fatal amount of fentanyl.
Research published in the journal JAMA Network Open examined how teenagers in the United States perceive the risks associated with fentanyl use. The study analyzed responses from 3,820 students in 8th, 10th, and 12th grades who participated in the 2025 Monitoring the Future survey.
Researchers asked students how much risk they believed was associated with different levels of fentanyl use, including trying it once or twice, occasional use, and regular use.
The study found that younger adolescents were less likely to recognize fentanyl’s dangers compared with older students.
Among 8th-grade students, fewer than half believed that experimenting with fentanyl even once or twice carried a great risk. About 48% viewed occasional use as highly dangerous, while around 67% recognized regular use as a serious risk.
Awareness increased among older students. In 10th grade, about 64% considered experimental use highly risky, and nearly 78% viewed regular use as very dangerous. By 12th grade, around 70% recognized the risks of trying fentanyl, and approximately 85% considered regular use extremely risky.
Although older students showed greater awareness, the researchers noted that a concerning number of high school seniors still underestimated the dangers of fentanyl.
Another important finding was that some students did not know enough about fentanyl to judge its risks. Among 8th-grade students, approximately 17% selected that they could not answer because the drug was unfamiliar to them. This percentage was lower among older students but remained notable.
Lack of knowledge can create vulnerability. If teenagers do not understand what fentanyl is or how it appears in counterfeit drugs, they may be less prepared to recognize dangerous situations.
Public health experts suggest that education campaigns should not only warn young people about fentanyl but also explain what the drug is, where it may appear, and why even a single exposure can be dangerous.
The research also identified differences in fentanyl risk awareness among demographic groups.
Students living in rural areas generally reported higher levels of perceived risk, particularly among younger grades. The study authors suggested that rural prevention programs may provide useful lessons for improving awareness elsewhere.
Differences were also found among racial and ethnic groups. Non-Hispanic White students were more likely to identify fentanyl use as highly risky across grades and types of use. Hispanic students in 8th grade and non-Hispanic Black students in later grades showed lower levels of perceived risk in some categories.
These differences do not mean that certain groups are naturally less aware. Instead, they may reflect differences in access to health education, prevention messaging, community resources, and exposure to information about fentanyl.
The findings suggest that prevention campaigns may be more effective when they are designed with specific communities in mind rather than using a single message for everyone.
Simply telling teenagers that fentanyl is dangerous may not be enough for all groups. Some young people may not have enough information about the drug, while others may underestimate the consequences because of limited understanding or risk-taking behaviors.
Adolescence is a period when many individuals are more likely to seek new experiences and underestimate possible dangers. Because of this, public health messages need to be clear, realistic, and delivered through channels teenagers actually use.
Schools, healthcare providers, parents, and community organizations can all play important roles. Conversations about fentanyl should happen before young people encounter the drug, not only after a crisis occurs.
Effective fentanyl education should focus on several key points:
Prevention programs may also benefit from using digital platforms and social media to reach teenagers directly. Young people increasingly receive information online, making these platforms important tools for public health communication.
The study’s findings show that many adolescents still need more information about fentanyl and its dangers. While awareness improves as teenagers get older, gaps remain across age groups and communities.
Reducing overdose deaths requires more than one solution. Education, prevention programs, family conversations, healthcare involvement, and community support all have a role in protecting young people.
Fentanyl’s risks are serious, but improving knowledge and awareness can help teenagers make safer decisions. Early education may be one of the most important steps in preventing accidental overdose and protecting the health of future generations.
This article is intended for general educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Anyone concerned about substance use, overdose risk, or addiction should seek guidance from qualified healthcare professionals or local support services.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.